Biosysco, a life science technology company that has developed a proven, patented, proprietary, medical therapy solution for humans and animals called SigmaQ, will locate its new equine medical technology division in Ocala, Florida.
“Biosysco is extremely pleased to become part of the Ocala and Florida business community,” said Steve Schmidt, Partner, BioSysco. “We believe this is the perfect fit for the development of our equine medical therapy division. As the Horse Capital of the world, Ocala offers us worldwide access to industry resources and we are excited about the growth opportunities for our equine medical division”.
SigmaQ activates and restores muscle damage at a neurological level, non-invasively and without drugs, according to Enterprise Florida. Biosysco utilizes its SigmaQ platform to identify and develop therapy solutions for multiple industries. Biosysco currently has offices in Chicago and London.
“Florida is proud to be the home of new advancements in the equestrian industry,” said Governor Ron DeSantis. “We are excited to welcome Biosysco to our great state and wish them all the success.”
“Biosysco’s expansion into Florida is a considerable achievement for the development of Florida’s economy,” said Jamal Sowell, President & CEO of Enterprise Florida, Inc. “Florida is proving to be a pioneer in the growth of the life sciences industry.”
“Second-stage company recruitment is a new area of focus at the CEP,” said Angie Lewis, Chair of the CEP Board of Directors. “We are excited to welcome BioSysco to Ocala. We look forward to attracting more of these high-growth companies as we continue to further diversify our local economy.”